SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Pharma’s arm recalls ‘Tacrolimus Ointment’ in US markets

16 Aug 2022 Evaluate

Glenmark Pharmaceuticals’ New Jersey-based subsidiary -- Glenmark Pharmaceuticals Inc, is recalling over 6.5 lakh tubes of a generic skin treatment ointment ‘Tacrolimus Ointment’ in US markets which is used to treat eczema. The recall is due to ‘Defective Container’. The company initiated the nationwide Class III recall on July 11 this year. The affected lot has been manufactured in India and distributed in the US by Glenmark Pharmaceuticals Inc.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.

Glenmark Pharma Share Price

2364.35 -6.70 (-0.28%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×